Objective Restorative options for Parkinson’s disease mainly contain L-dopa and dopamine agonists. dopamine agonists markedly reduced and non-ergot dopamine agonists elevated after 2007. Among first-line medications, the percentage of non-ergot realtors increased after Apr 2007. Among 54 cabergoline/pergolide users, 24 (44%) discontinued these medications, nine of whom turned to non-ergot realtors. Bottom line L-dopa was… Continue reading Objective Restorative options for Parkinson’s disease mainly contain L-dopa and dopamine